title: Transfecting and nucleofecting human induced pluripotent stem cells.
abstract: Genetic modification is continuing to be an essential tool in studying stem cell biology and in setting forth potential clinical applications of human embryonic stem cells (HESCs). While improvements in several gene delivery methods have been described, transfection remains a capricious process for HESCs, and has not yet been reported in human induced pluripotent stem cells (iPSCs). In this video, we demonstrate how our lab routinely transfects and nucleofects human iPSCs using plasmid with an enhanced green fluorescence protein (eGFP) reporter. Human iPSCs are adapted and maintained as feeder-free cultures to eliminate the possibility of feeder cell transfection and to allow efficient selection of stable transgenic iPSC clones following transfection. For nucleofection, human iPSCs are pre-treated with ROCK inhibitor, trypsinized into small clumps of cells, nucleofected and replated on feeders in feeder cell-conditioned medium to enhance cell recovery. Transgene-expressing human iPSCs can be obtained after 6 hours. Antibiotic selection is applied after 24 hours and stable transgenic lines appear within 1 week. Our protocol is robust and reproducible for human iPSC lines without altering pluripotency of these cells.
authors: UCR Stem Cell Center, Department of Cell Biology and Neuroscience, University of California Riverside, USA.
authors: Papri
authors: P
authors: Chatterjee
authors: Yuri
authors: Y
authors: Cheung
authors: Chee
authors: C
authors: Liew
mesh_terms: D018929:Cell Culture Techniques; D018274:Electroporation / Q000379:methods; D006801:Humans; D039904:Pluripotent Stem Cells / Q000166:cytology / Q000502:physiology*; D014162:Transfection / Q000379:methods*; D019076:Transgenes